{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:40:04Z","timestamp":1750538404167,"version":"3.41.0"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 61-year-old man was hospitalized for suspected cardiac amyloidosis. <jats:sup>99m<\/jats:sup>Tc-Pyrophosphate scintigraphy showed intense radiotracer uptake in the heart compared with the ribs, suggestive of transthyretin cardiac amyloidosis. Subsequent genetic test showed missense mutations in the transthyretin gene, which confirmed the diagnosis. Incidentally, a regional radiotracer uptake was seen in the bilateral lungs, respectively, corresponding to areas of atelectasis on the localizing CT of the SPECT\/CT. Attention should be paid to radiotracer retention in lung atelectasis as it influences the H\/CL (heart\u2013to\u2013contralateral lung) ratio calculation and may hinder the diagnosis of cardiac amyloidosis based on the quantitative H\/CL ratio.<\/jats:p>","DOI":"10.1097\/rlu.0000000000003816","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T15:12:20Z","timestamp":1626448340000},"page":"820-821","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["99mTc-Pyrophosphate Retention in Atelectatic Pulmonary Tissues of a Patient With Transthyretin Cardiac Amyloidosis"],"prefix":"10.1097","volume":"46","author":[{"given":"Yu","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yilei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yun","family":"Xi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yifan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,7,15]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1001\/jamacardio.2016.2839","article-title":"Multicenter study of planar technetium 99m pyrophosphate cardiac imaging: predicting survival for patients with ATTR cardiac amyloidosis","volume":"1","year":"2016","journal-title":"JAMA Cardiol"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1007\/s11886-011-0239-5","article-title":"Molecular imaging of amyloidosis: will the heart be the next target after the brain?","volume":"14","year":"2012","journal-title":"Curr Cardiol Rep"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s11886-018-0970-2","article-title":"Clinical phenotyping of transthyretin cardiac amyloidosis with bone-seeking radiotracers in heart failure with preserved ejection fraction","volume":"20","year":"2018","journal-title":"Curr Cardiol Rep"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1007\/s00259-018-3995-2","article-title":"Extracardiac 18F-florbetapir imaging in patients with systemic amyloidosis: more than hearts and minds","volume":"45","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/13506129.2018.1552852","article-title":"A pilot study demonstrating cardiac uptake with 18F-florbetapir PET in AL amyloidosis patients with cardiac involvement","volume":"25","year":"2018","journal-title":"Amyloid"},{"key":"bib6-20250621","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1080\/13506129.2018.1467313","article-title":"Utility of the 18F-Florbetapir positron emission tomography in systemic amyloidosis","volume":"25","year":"2018","journal-title":"Amyloid"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s12350-016-0768-9","article-title":"Technetium pyrophosphate uptake in transthyretin cardiac amyloidosis: associations with echocardiographic disease severity and outcomes","volume":"25","year":"2018","journal-title":"J Nucl Cardiol"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/s12350-016-0610-4","article-title":"Standardization of 99mTechnetium pyrophosphate imaging methodology to diagnose TTR cardiac amyloidosis","volume":"25","year":"2018","journal-title":"J Nucl Cardiol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003816","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:02:18Z","timestamp":1750536138000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003816"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,15]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003816","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2021,7,15]]}}}